Skip to main content

Advertisement

Log in

Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the effect of 10-week treatment with intranasal insulin (0.5 IU/day) on glucose tolerance, glucose utilization, lipid metabolism, functions of pancreatic β cells, and insulin system in the liver of rats with cafeteria diet-induced metabolic syndrome. The therapy reduced body weight and blood levels of insulin, triglycerides, and atherogenic cholesterol that are typically increased in metabolic syndrome, normalized glucose tolerance and its utilization, and increased activity of insulin signaling system in the liver, thus reducing insulin resistance. The therapy did not affect the number of pancreatic islets and β cells. The study demonstrates prospects of using intranasal insulin for correction of metabolic parameters and reduction of insulin resistance in metabolic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kuznetsova LA, Sharova TS, Pertseva MN, Shpakov AO. Beta-adrenergic regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin administration. J. Evol. Biochem. Physiol. 2015;51(3):198-209.

    Article  CAS  Google Scholar 

  2. Sukhov IB, Derkach KV, Chistyakova OV, Bondareva VM, Shpakov AO. Functional state of hypothalamic signaling systems in rats with type 2 diabetes mellitus treated with intranasal insulin. J. Evol. Biochem. Physiol. 2016;52(3):204-216.

    Article  CAS  Google Scholar 

  3. Shpakov AO. Functional activity of the brain insulin signaling system in norm and in type 2 diabetes mellitus. Ross. Fiziol. Zh. 2015;101(10):1103-1127. Russian.

  4. Shpakov AO, Derkach KV, Chistyakova OV, Moiseyuk IV, Sukhov IB, Bondareva VM. Effect of intranasal insulin and serotonin on functional activity of the adenylyl cyclase system in myocardium, ovary, and uterus of rats with prolonged neonatal model of diabetes mellitus. J. Evol. Biochem. Physiol. 2013;49(2):153-164.

    Article  CAS  Google Scholar 

  5. Bedse G, Di Domenico F, Serviddio G, Cassano T. Aberrant insulin signaling in Alzheimer’s disease: current knowledge. Front. Neurosci. 2015;9:204. doi: 10.3389/fnins.2015.00204.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Derkach KV, Bogush IV, Berstein LM, Shpakov AO. The Influence of intranasal insulin on hypothalamic-pituitarythyroid axis in normal and diabetic rats. Horm. Metab. Res. 2015;47(12):916-924.

    Article  CAS  PubMed  Google Scholar 

  7. Derkach KV, Bondareva VM, Chistyakova OV, Berstein LM, Shpakov AO. The effect of long-term intranasal serotonin treatment on metabolic parameters and hormonal signaling in rats with high-fat diet/low-dose streptozotocin-induced type 2 diabetes. Int. J. Endocrinol. 2015;2015. ID 245459. doi: 10.1155/2015/245459.

  8. Dong X, Park S, Lin X, Copps K, Yi X, White MF. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J. Clin. Invest. 2006;116(1):101-114.

    Article  CAS  PubMed  Google Scholar 

  9. Freiherr J, Hallschmid M, Frey WH 2nd, Brünner YF, Chapman CD, Hölscher C, Craft S, De Felice FG, Benedict C. Intranasal insulin as a treatment for Alzheimer’s disease: a review of basic research and clinical evidence. CNS Drugs. 2013;27(7):505-514.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Gancheva S, Koliaki C, Bierwagen A, Nowotny P, Heni M, Fritsche A, Häring HU, Szendroedi J, Roden M. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans. Diabetes. 2015;64(6):1966-1975.

    Article  CAS  PubMed  Google Scholar 

  11. Hallschmid M, Benedict C, Schultes B, Born J, Kern W. Obese men respond to cognitive but not to catabolic brain insulin signaling. Int. J. Obes. (Lond.). 2008;32(2):275-282.

    Article  CAS  Google Scholar 

  12. Lam DW, LeRoith D. Metabolic syndrome. Endotext [Internet]. De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, eds. South Dartmouth, 2015. PMID: 25905173. URL: https://www.ncbi.nlm.nih.gov/pubmed/25905173.

  13. Ott V, Benedict C, Schultes B, Born J, Hallschmid M. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism. Diabetes Obes. Metab. 2012;14(3):214-221.

    Article  CAS  PubMed  Google Scholar 

  14. Shpakov AO, Chistyakova OV, Derkach KV, Moiseyuk IV, Bondareva VM. Intranasal insulin affects adenylyl cyclase system in rat tissues in neonatal diabetes. Central Eur. J. Biol. 2012;7(1):33-47. doi: 10.2478/s11535-011-0089-6.

    CAS  Google Scholar 

  15. Zhang H, Hao Y, Manor B, Novak P, Milberg W, Zhang J, Fang J, Novak V. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes. 2015;64(3):1025-1034.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. O. Shpakov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 2, pp. 144-149, February, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Derkach, K.V., Ivantsov, A.O., Chistyakova, O.V. et al. Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome. Bull Exp Biol Med 163, 184–189 (2017). https://doi.org/10.1007/s10517-017-3762-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3762-6

Key Words

Navigation